Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL003759

Drug Information
NameLixisenatide
Trade NameLyxumia
CompanySanofi
IndicationType 2 diabetesRegistration    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C215H347N61O65S/c1-16-115(10)173(210(337)256-141(68-74-170(299
)300)194(321)261-148(94-122-98-232-126-50-24-23-49-124(122)126)19
9(326)258-143(89-111(2)3)196(323)247-134(58-32-40-83-223)189(316)
262-149(96-160(226)285)180(307)235-100-161(286)233-104-165(290)27
4-85-42-60-156(274)207(334)267-154(108-280)206(333)265-151(105-27
7)181(308)237-101-162(287)239-117(12)213(340)276-87-44-62-158(276
)214(341)275-86-43-61-157(275)208(335)268-153(107-279)204(331)249
-132(56-30-38-81-221)187(314)246-131(55-29-37-80-220)186(313)245-
130(54-28-36-79-219)185(312)244-129(53-27-35-78-218)184(311)243-1
28(52-26-34-77-217)183(310)242-127(176(227)303)51-25-33-76-216)27
2-201(328)146(92-120-45-19-17-20-46-120)260-197(324)144(90-112(4)
5)257-190(317)135(59-41-84-231-215(228)229)255-209(336)172(114(8)
9)271-177(304)116(11)240-182(309)138(65-71-167(293)294)251-192(31
9)139(66-72-168(295)296)252-193(320)140(67-73-169(297)298)253-195
(322)142(75-88-342-15)254-191(318)137(63-69-159(225)284)250-188(3
15)133(57-31-39-82-222)248-203(330)152(106-278)266-198(325)145(91
-113(6)7)259-200(327)150(97-171(301)302)263-205(332)155(109-281)2
69-212(339)175(119(14)283)273-202(329)147(93-121-47-21-18-22-48-1
21)264-211(338)174(118(13)282)270-164(289)103-236-179(306)136(64-
70-166(291)292)241-163(288)102-234-178(305)125(224)95-123-99-230-
110-238-123/h17-24,45-50,98-99,110-119,125,127-158,172-175,232,27
7-283H,16,25-44,51-97,100-109,216-224H2,1-15H3,(H2,225,284)(H2,22
6,285)(H2,227,303)(H,230,238)(H,233,286)(H,234,305)(H,235,307)(H,
236,306)(H,237,308)(H,239,287)(H,240,309)(H,241,288)(H,242,310)(H
,243,311)(H,244,312)(H,245,313)(H,246,314)(H,247,323)(H,248,330)(
H,249,331)(H,250,315)(H,251,319)(H,252,320)(H,253,322)(H,254,318)
(H,255,336)(H,256,337)(H,257,317)(H,258,326)(H,259,327)(H,260,324
)(H,261,321)(H,262,316)(H,263,332)(H,264,338)(H,265,333)(H,266,32
5)(H,267,334)(H,268,335)(H,269,339)(H,270,289)(H,271,304)(H,272,3
28)(H,273,329)(H,291,292)(H,293,294)(H,295,296)(H,297,298)(H,299,
300)(H,301,302)(H4,228,229,231)/t115-,116-,117-,118+,119+,125-,12
7-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,14
0-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,15
3-,154-,155-,156-,157-,158-,172-,173-,174-,175-/m0/s1
InChIKeyXVVOERDUTLJJHN-IAEQDCLQSA-N
Canonical SMILESCCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)
NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC
(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C
(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=
O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)
C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C
(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C
(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC
(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CN=CN8)N    
Isomeric SMILESCC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C
(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)
NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)
C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)
N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C
(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CC6=CC=CC=C6)NC(=O)[C@H](CC(C)C)NC
(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)
O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H]
(CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@
H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC7=CC=CC=
C7)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H]
(CC8=CN=CN8)N
FormulaC215H347N61O65S
PubChem Compound IDCID 16139342.
SuperDrug ATC IDA10BX10
TargetGLP-1



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.
   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 
Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543